Groupe Athena, Inc. announced that it has entered into a multiyear contract with Eskayef Bangladesh LTD. Under the terms of the agreement, the company will assist Eskayef in obtaining FDA approval for their Bangladesh manufacturing facility during the first stage, and assist with U.S. approval of individual drugs in subsequent stages of the agreement. The contract could result in a 20% increase to annual revenues beginning fiscal 2014.